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Male Infertility
The desire to have children is a natural instinct, yet in-
fertility is an age-old problem that has plagued human-
kind since Abraham and Sarah. Infertility in humans is
an issue that affects 10%–15% of couples, and approx-
imately half of these cases of infertility are attributable
to men. The categories of treatment for infertile men are
separated into three groups. The first group, men with
an untreatable sterility condition, comprises 12% of in-
fertile men (Baker et al. 1986). Obvious causes are pre-
sent in approximately one-third of these patients and
include Klinefelter syndrome, undescended testes, testic-
ular torsion, trauma, and exposure to cytotoxic agents
or radiotherapy producing testicular atrophy (Baker
1994). Additional causes include idiopathic primary
seminiferous tubule failure with appearances, on testic-
ular biopsy specimens, of Sertoli cell only (no germ cells)
or germ-cell arrest (Baker 1994). The second group, men
with a potentially treatable condition, comprises 13%
of infertile men (Baker et al. 1986). Potentially treatable
conditions include genital tract obstructions, sperm au-
toimmunity, gonadotropin deficiency, coital disorders,
and reversible impairment of semen quality (Baker
1994). The third group, men with an untreatable sub-
fertility, comprises 75% of infertile men (Baker et al.
1986). These men are either oligospermic, in that they
produce less than the normal number of sperm (!20
million sperm/ml; World Health Organization 1992), or
asthenozoospermic, in that a high percentage of sperm
is immotile. In a study presented in this issue of the
Journal, Ruiz-Pesini et al. (2000) describe their finding
of a likely cause of asthenozoospermia—namely, mu-
tations in mtDNA—in some men.
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The Genetics of Infertility
In recent years, three candidate genes have been impli-
cated in genetic infertility in men. The DAZ (deleted in
azoospermia) gene, which is located in a cluster on the
AZFc (azoospermia factor) region of the Y chromosome,
has been shown to be deleted in 10%–15% of oligo-
spermic and azoospermic men (Reijo et al. 1995, 1996;
Pryor et al. 1997). The RBM (RNA-binding motif) gene
homologues, which are located throughout the Y-chro-
mosome, are actively transcribed in the AZFb region
(Ma et al. 1993; Elliott and Cooke 1997). Deletions in
the AZFb region have also been found in azoospermic
and oligospermic men (Ma et al. 1993; Elliott and Cooke
1997). Additional deletions encompassingDFFRY (Dro-
sophila fat facets related Y), a gene located in the AZFa
region of the Y chromosome, have also been observed
in a small percentage of infertile men (Brown et al.
1998). These genes have different expression patterns:
DAZ and RBM are testis specific, with transcription re-
stricted to germ cells (Ma et al. 1993; Reijo et al. 1995),
whereas DFFRY is expressed in a wide range of tissues
(Brown et al. 1998). The functions of these genes remain
to be determined, but evidence strongly suggests a role
for both DAZ and RBM in germ-cell development in
men.
Evidence that supports a role for genetics in human
infertility is rare. The most concrete method to examine
the genetics of infertility is to screen for a mutation(s)
or deletions(s) in candidate gene(s). This method has
been used successfully by Ruiz-Pesini et al. (2000 [in
this issue]). They have identified mutations in mtDNA
that are implicated in an asthenozoospermic phenotype.
Mitochondrial Genetics
Mutations in the mitochondria have been implicated in
a variety of human diseases ranging from degenerative
diseases and aging to infertility (Følgero et al. 1993;
Wallace 1995). This may be because of the increase in
the number of mutations in mitochondria, which is the
result of several properties that make mtDNA distinct
from cellular DNA. First, replication of mtDNA is rapid
and lacks proofreading (Clayton et al. 1974; Fukunaga
et al. 1979). This results in a mitochondrial mutation
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rate that is 10–100 times higher than that of nuclear
DNA (Richter et al. 1988; Nagley et al. 1993). In ad-
dition, mitochondria lack an adequate DNA-repair
mechanism, which can further increase the mutation rate
(Clayton et al. 1974). Finally, the mode of inheritance
of mitochondria is unique because the genetic infor-
mation is inherited maternally. This creates an asym-
metry in the natural selection process. mtDNA variations
may be more prevalent because the mtDNA mutation
rate is higher and because selection occurs only in fe-
males. For example, if a germline mitochondrial muta-
tion arises that has serious effects in the male only, it
could be passed with high frequency from generation to
generation, since natural selection occurs only in fe-
males.
Current understanding of the role of mitochondrial
mutations in human disease is expanding. Tissues that
require high levels of respiratory energy, such as the
brain, heart, skeletal muscle, kidney, liver, endocrine
system, and other somatic tissues, can malfunction if
they possess defects in their mitochondria (Johns 1995).
Sperm are also included in this category. It has been
proposed that the ATP produced by mitochondria is
essential for sperm motility (Mitchell et al. 1976). Other
evidence supports an essential role for mitochondrial
formation and function in spermatogenesis (Følgero et
al. 1993; Kao et al. 1995; Frank and Hurst 1996; St.
John et al. 1997; Zeviani and Antozzi 1997; Ruiz-Pesini
et al. 1998).
Mitochondrial Structure in Spermatozoa
The maturation of spermatogonia to a spermatozoon
capable of fertilization involves rearrangement of mi-
tochondria and development of a functional tail. As-
thenozoospermia could potentially be caused by defects
in tail formation in spermatozoa or by defects in the
energy-producing machinery required to drive motility.
In sperm, mitochondria are located around the midpiece
and are arranged in a helix of 11–13 gyri (or individual
spirals around the core), with two mitochondria per gy-
rus (Zamboni et al. 1991). In the absence of glycolytic
support, ATP generated from the mitochondria is deliv-
ered to the axoneme and is used for flagellar propulsion.
Reductions in motility could potentially arise from de-
fects in any of the 200–300 separate genes that are nec-
essary for proper assembly and function of the sperm
axoneme and tail. “Primary ciliary dyskinesia” (PCD)
and “immotile cilia syndrome” are terms used to des-
ignate a diverse constellation of syndromes in which cil-
iated structures within the body are dysfunctional (Oates
1998). Defects in spermatozoa tail formation can include
a lack of inner or outer dynein arms, the absence of
radial spokes, or the deletion of the central or outer
doublets (arrays of microtubules composed of a com-
plete and partial microtubule that share a common wall).
Previous research has also suggested a correlation be-
tween mitochondrial volume and sperm length and fla-
gellar beat frequency (Cardullo and Baltz 1991). More-
over, the sperm midpiece length has been shown to be
significantly shorter in asthenozoospermic subjects than
in normal subjects (Mundy et al. 1995). In brief, mu-
tations in mtDNA could contribute to a large percentage
of asthenozoospermia. Kao et al. (1995) identified an
accumulation of a 4,977-bp deletion in the mtDNA of
spermatozoa of men with infertility or subfertility. The
deletion was observed in normal individuals, but the
highest frequency of occurrence was in men with the
lowest sperm motility. The results revealed a negative
correlation between sperm motility and the proportion
of 4,977 bp of deleted mtDNA.
Mitochondria Enzymatic Complexes Needed for
Sperm Motility
The primary goal of the study by Ruiz-Pesini et al.
(2000) was to investigate whether fixed mtDNA variants
have phenotypic consequences in human sperm quality.
The authors first established that the motility of human
spermatozoa is fully dependent on the functionality of
the oxidative phosphorylation pathway. The electron-
transfer chain, which produces the energy generated by
mitochondria, is composed of four multimeric enzymatic
complexes (complexes I–IV; fig. 1). Three of the four
multimeric complexes (complexes I, III, and IV) are par-
tially encoded by mtDNA. Ruiz-Pesini et al. used drugs
that specifically inhibit the activity of these complexes,
to demonstrate the progressive impairment of sperm mo-
tility and to ultimately block flagellar movement. Their
observation underscores the importance of mitochon-
drial activity in sperm motility. It is supported by the
results of studies in which inhibitors of mitochondrial
energy metabolism (Ford and Harrison 1981; Halangk
et al. 1985; Weinberg et al. 1995; Pascual et al. 1996)
were used and the enzymatic activities of spermatozoa
with normal and impaired motility were measured
(Ruiz-Pesini et al. 1998).
mtDNA Haplogroup Associated with
Asthenozoospermia
On the basis of their observation that inhibitors of mi-
tochondrial activity reduced sperm motility, Ruiz-Pesini
et al. decided to investigate the potential genetic asso-
ciation between mtDNA variance and sperm motility.
The authors used sperm samples from 545 donors (pre-
dominantly whites) and characterized the mtDNA into
known haplogroups on the basis of polymorphic sites
in the mtDNA (Richard et al. 1996; Torroni et al. 1996,
1997; Brown et al. 1997; Hofmann et al. 1997a, 1997b).
They then grouped the sperm samples, on the basis of
sperm motility, into three groups: nonasthenozoopermic
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Figure 1 Substrates enter the respiratory chain at complex I and II and deliver electrons to complex III. Complex III delivers electrons
to complex IV and reduces oxygen atoms inside the matrix to H2O. A proton-motive force is generated in the intermembrane space by coupling
electron transport to proton translocation at complexes I, III, and IV. The enzyme ATP synthetase generates ATP when protons are transported
down their concentration gradient into the matrix. Complexes I, III, and IV, which are crucial for generating the proton-motive force, are
partially encoded by mtDNA.
(non-AP; 50% of progressive spermatozoa), moder-
ately asthenozoospermic phenotype (MAP; 25% and
!50% of progressive spermatozoa), and severely as-
thenozoospermic phenotype (SAP; !25% of progressive
spermatozoa). They analyzed the percentage of the dif-
ferent haplogroups in each motility group. A significant
overrepresentation of haplogroup H was found in the
non-AP individuals (normal sperm motility), and a sig-
nificant overrepresentation of haplogroup T was found
in the MAP individuals (reduced sperm motility), even
though both haplogroups belong to a population of
white males. The authors also observed a significant dif-
ference between the maximum swimming distance for
sperm from haplogroup H and that for sperm from hap-
logroup T, with the distance for sperm from haplogroup
H being longer. These results established a correlation
between mtDNA variation and sperm motility.
Identification of Possible Cause for Type T–Associated
Asthenozoospermia
Ruiz-Pesini et al. (2000) next investigated the molecular
mechanism that might underlie the observed association
of haplogroup-T mtDNA and reduced spermatozoa mo-
tility. This was accomplished through analysis of the
enzymatic activities of the different mitochondrial com-
plexes within each haplogroup. Of interest, two multi-
meric complexes (complexes I and IV) that are partially
encoded by mtDNA showed a significantly lower activity
when assayed from haplogroup T, compared with hap-
logroup H. In contrast, the mitochondrial enzymatic
complex II, which is encoded only by nuclear DNA, did
not show any difference in activity when compared be-
tween haplogroups H and T. Finally, to determine a pos-
sible cause for the lower mitochondrial performance seen
in haplogroup T, compared with the mitochondrial per-
formance seen in other haplogroups, the authors looked
for mutations in genes encoded by the mtDNA. Several
polymorphic markers in haplogroup T introduce at least
two amino acid changes in the primary sequence for the
enzymatic complex I gene. These mutations could ex-
plain the lower performance of complex I in the mtDNA
of individuals carrying haplogroup T. In addition, Ruiz-
Pesini et al. (2000) identified two mutations in the ar-
ginine and threonine tRNAs in the mtDNA of individ-
uals carrying haplogroup T. Both tRNA mutations were
previously identified (MITOMAP: A Human Mitochon-
drial Genome Database) and described as T-specific
polymorphic sites (Macaulay et al. 1999). Further mo-
lecular analysis will be needed to determine whether any
of these tRNA variants—alone or synergistically—has
an influence on mitochondrial protein synthesis that
could explain the lower performance of complex IV in
organelles carrying haplogroup-T mtDNA (Ruiz-Pesini
et al. 2000).
Impact of the Finding on Infertility
The way that we identify and characterize the cause of
untreatable subfertility will be greatly impacted by the
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finding of Ruiz-Pesini et al. that mutations in mtDNA
are associated with low sperm motility. Asthenozoo-
spermia is not rare. It may either contribute to or be the
primary cause of infertility in 30% of infertile men.
Mutations in mtDNA could be either the primary cause
of or a secondary contributing factor to asthenozoo-
spermia in a significant portion of these men. Because
there exist 200–300 proteins (all of which are encoded
by nuclear genes) that are needed for proper tail for-
mation (Oates 1998), heterozygous mutations in these
genes on a weak mitochondrial background (haplogroup
T) could result in varying degrees of severity of
asthenozoospermia. Thus, the results of analysis, at the
morphological level, of the sperm from asthenozoo-
spermic patients may indicate an increased percentage
of nonmotile sperm, but other hidden factors could be
affecting the quality of sperm from such patients.
The lack of effective treatments for defects in sperm
quality and production prompts the use of assisted re-
productive techniques such as IVF (in vitro fertilization)
or ICSI (intracytoplasmic single-sperm injection) to
treat infertile couples. There are a number of increased
risks associated with the use of IVF or, more recently,
ICSI. The use of sperm from oligospermic or azoo-
spermic men for ICSI is one risk, because of the possible
defects in nuclear genes required for cellular function.
For example, Nudell at el. (2000) showed that the mu-
tation rate is higher in the germline DNA, compared
with the somatic (blood) DNA, of men with meiotic
arrest or incomplete meiotic arrest (oligospermic). This
finding suggests that oligospermic or azoospermic men
may have defects in their meiosis-specific DNA-repair
enzymes. The use of their sperm, which have passed the
meiotic checkpoint for ICSI, may have a serious effect
on the health of a child, as a result of defects in the
nuclear genes required to repair DNA. If we carefully
consider the implications of the use of sperm from men
in the untreatable subfertility group (oligospermic and
asthenozoospermic men), then possible defects in the
nuclear DNA and even the mtDNA could have a com-
bined effect on the health of a child.
The finding by Ruiz-Pesini et al. that variations in
mtDNA between different haplogroups play a role in
asthenozoospermia also suggests that variations in
mtDNA may underlie other human characteristics.
Since mutations in mtDNA accumulate sequentially
along radiating female lineages, individual mtDNA line-
ages have diverged as women have migrated from Africa
and into the various continents during the ∼150,000
years of human evolution (Wallace 1995). Each ethnic
group contains population-specific polymorphisms.
Haplotyping the mtDNA of different lineages may help
us to understand more about human diseases or even
the characteristics that might be associated with mu-
tations in mtDNA.
It is of interest that this is the first instance of a mi-
tochondrial mutation that has an affect on the health
of men but not on that of women. Additional mito-
chondrial mutations that lead to male-specific diseases
could be predicted on the basis of the fact that mito-
chondrial selection occurs only in females. This new
finding by Ruiz-Pesini et al. raises new questions and
issues that need to be considered in the field of infertility.
Does the lower performance of the mitochondria of
these men who are carrying haplogroup T predispose
them to complex disorders (heart conditions, etc.) re-
sulting from some environmental exposure later in life?
Do women who harbor these same mutations have the
same risk? Can we retrace, in certain ethnic groups, the
origin of mtDNA mutations that cause prevalent dis-
ease? The impact of this finding gives the scientific com-
munity a new tool with which to analyze the choices
used to treat human disease and to safely treat infertility
in males.
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